Open AccessEarly measurements of serum ustekinumab concentrations predict efficacy for remission in patients with Crohn's disease
Author(s) -
Sanjeevani Tomar
Publication year - 2022
Publication title -
gijournal
Language(s) - English
Resource type - Journals
ISSN - 2768-1564
DOI - 10.52697/gijournal.v2i1.34
Subject(s) - ustekinumab , crohn's disease , medicine , disease , crohn disease , complete remission , gastroenterology , chemotherapy , infliximab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom